Aplidn Fase II Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma .

*.- Estimated Enrollment: 58 .
*.- Study Start Date: December 2004 .
*.- Estimated Study Completion Date: March 2010 .
*.- Estimated Primary Completion Date: March 2010 (Final data collection date for primary outcome measure) .